Bioneer Corporation

₩6,350As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:064550Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (2.27%)
Div yield —
ROE (1.64%)
Biotechnology
Beta (5Y) 0.42
PE TTM —
TSR TTM (59.03%)
Mkt cap ₩163.9B
ROIC (2.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,510
2.51%
(74.49%)
Hold 2|8|6|10|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
76.61
73.85
74.87
83.51
5.08%
4.25%
(0.41%)
8.83%
Revenue₩B
10.63
10.90
10.66
10.74
9.89%
9.81%
2.68%
1.18%
Peers (US$120.8M)
Cap (US$)
PE
120.5M
30.07x
117.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.315
(0.091)
(0.072)
EBIT/Intx
0.115
0.150
0.173
Own earn%
(11.76)
(22.43)
(20.61)
Sh yield%
32.60
10.45
10.38
Owners
Insiders/Inst%
12.89
48.51
Short interest%
1.80
SBC / revenue%
3.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
7–12
$1 testx
—
Incr. ROIC%
−1